FN2 Earnings Intelligence
Tenet Healthcare Corporation financials
Tenet Healthcare Corporation (THC) financial statements and key operating metrics from FN2 Research.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - |
| - Cash | $2,364 | $858 | $1,228 | $3,019 | $2,883 |
| + Debt | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - |
| Revenue | $19,485 | $19,174 | $20,548 | $20,665 | $21,310 |
| % Growth | 10.5% | -1.6% | 7.2% | 0.6% | 3.1% |
| Gross Profit | - | - | - | - | - |
| % Margin | - | - | - | - | - |
| EBITDA | $3,726 | $3,174 | $3,380 | $6,774 | $4,371 |
| % Margin | 19.1% | 16.6% | 16.4% | 32.8% | 20.5% |
| Net Income | $1,476 | $1,001 | $1,311 | $4,064 | $2,367 |
| % Margin | 7.6% | 5.2% | 6.4% | 19.7% | 11.1% |
| Diluted EPS | $8.42 | $3.79 | $5.71 | $32.70 | $15.49 |
| % Growth | 124.5% | -55.0% | 50.7% | 472.7% | -52.6% |
| Operating Cash Flow | $1,568 | $1,083 | $2,374 | $2,047 | $3,540 |
| CapEx | $658 | $762 | $751 | $931 | $1,010 |
| Free Cash Flow | $910 | $321 | $1,623 | $1,116 | $2,530 |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue | $19,485 | $19,174 | $20,548 | $20,665 | $21,310 |
| Gross Profit | - | - | - | - | - |
| EBITDA | $3,726 | $3,174 | $3,380 | $6,774 | $4,371 |
| Net Income | $1,476 | $1,001 | $1,311 | $4,064 | $2,367 |
| Diluted EPS | $8.42 | $3.79 | $5.71 | $32.70 | $15.49 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $2,364 | $858 | $1,228 | $3,019 | $2,883 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | - | - | - | - | - |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1,568 | $1,083 | $2,374 | $2,047 | $3,540 |
| Capital Expenditure | $658 | $762 | $751 | $931 | $1,010 |
| Free Cash Flow | $910 | $321 | $1,623 | $1,116 | $2,530 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue Growth | 10.5% | -1.6% | 7.2% | 0.6% | 3.1% |
| Gross Margin | - | - | - | - | - |
| EBITDA Margin | 19.1% | 16.6% | 16.4% | 32.8% | 20.5% |
| Net Margin | 7.6% | 5.2% | 6.4% | 19.7% | 11.1% |
| FCF Margin | 4.7% | 1.7% | 7.9% | 5.4% | 11.9% |
| Diluted EPS Growth | 124.5% | -55.0% | 50.7% | 472.7% | -52.6% |
Get the THC recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.